Sounds good. My point being if somebody allegedly sabotaged a multi-billion dollar drug phase 2 trial ten years ago and to date the drug has not earned a penny of revenue (other than being sold for $8m about 5 years ago) and hasn't sniffed a phase three, then maybe it isn't worth much.